Anti-D in Pregnancy: Questions, Choices, and What You Need to Know

Written By Rachel Mepham

Being Rh negative can feel like carrying a quiet, heavy decision that no one talks about. Anti-D immunoglobulin is routinely offered in pregnancy and after birth, but asking real questions about it can feel isolating — especially in a world where it’s usually presented as automatic: if you’re Rh negative, you will have blood products.

At Birthsong Midwifery, I believe informed choice matters. It’s okay to ask questions, to be unsure, and to explore what is right for you and your baby.

What is Anti-D?

Anti-D (also called RhoGAM, RhIG, or Rh₀(D) immunoglobulin) is a blood product made from human plasma. It contains antibodies designed to prevent an Rh-negative woman from becoming sensitised to Rh-positive blood.

Sensitisation can occur during:

  • Birth

  • Miscarriage or termination

  • Bleeding in pregnancy

  • Procedures or any event where fetal blood cells mix with maternal blood

Important: Anti-D does not protect your current baby. Its purpose is to reduce risk for future pregnancies, particularly the risk of haemolytic disease of the newborn (HDFN) in Rh-positive babies.

How is Anti-D Made?

Plasma for Anti-D comes from donors who have high levels of anti-D antibodies, either naturally or via deliberate immunisation. Plasma from thousands of donors is pooled, processed, and purified to make the medicine.

Because of this pooling:

  • Anti-D made only from “unvaccinated blood” is not possible

  • Vaccination status is not recorded or separated

  • Even if it were, controlling donor plasma at this scale is logistically impossible

Sara Wickham explains this clearly in her article Can Anti-D be made from unvaccinated blood? and her book Anti-D Explained — both excellent resources if you want to explore the science and ethics further.

NICE Guidelines and the Evidence Base

In the UK, Anti-D is offered according to NICE guidance:

  • One antenatal dose around 28–30 weeks or

  • Two doses (28 & 34 weeks)

  • Postnatal dose if the baby is Rh positive

Evidence shows Anti-D reduces sensitisation risk, but it does not prevent it entirely. The research base is moderate, with some gaps and older studies informing recommendations. This is an important nuance: it’s risk reduction, not a guarantee.

Blood Tests and Antibody Screening

Not all Rh-negative women will become sensitised. Antibody screening (Group & Save) can reveal if sensitisation has already occurred — sometimes from a previous birth, miscarriage, termination, or unnoticed fetal–maternal blood mixing.

A note of caution: if you’ve recently had Anti-D, your antibody screen may be positive because of passive antibodies from the injection, not because your body has produced them. Timing and interpretation matter — this is where a knowledgeable midwife or clinician can help.

Risks to Future Pregnancies

If sensitisation occurs and Anti-D isn’t given, risks include:

  • Haemolytic disease of the newborn (HDFN) in a future Rh-positive baby

  • Severity ranges from mild jaundice to serious complications requiring transfusions or early delivery

Many sensitised pregnancies are mild, and many women would never become sensitised. But the risk exists, and this is why Anti-D is offered.

Feeling Isolated: The Hidden Questions

These questions are rarely voiced. When I worked as a community midwife in the NHS, I had just one client who declined Anti-D. None of my colleagues had ever seen anyone question it.

Anti-D is still often presented as an absolute given:

👉 If you’re Rh negative, you will have Anti-D.

Now, in independent midwifery practice, I’m hearing these questions weekly. Families are quietly carrying doubts and fears — and that matters.

I know the fear of asking questions or sharing these concerns publicly. I felt it too. Seeing Sara Wickham’s post reminded me it’s okay to speak out, to be unsure, and to explore the options that feel right for you.

Alternatives and Informed Choice

For Rh-negative families, options include:

  • Following routine antenatal and postnatal Anti-D per NICE guidance

  • Monitoring with Group & Save / antibody screening to check for sensitisation

  • Making fully informed, personalised decisions with your midwife about timing, dosing, and necessity

No choice is automatically right or wrong — the key is having honest information, supportive care, and space to question.

Where to Learn More

A Final Thought

Asking questions about Anti-D is rare. Feeling unsure is normal. Wanting to understand fully before accepting treatment is valid.

Your choices are yours, your questions are valid, and you deserve to navigate them with support, honesty, and kindness.

You are not alone.

Rachel Mepham
Next

Imbolc, Pregnancy, and the Quiet Work of Birth